FDA & Florida Advance Strides on Kratom Regulation
- Posted on: 2024-02-01
- Views: 30
Recent developments in the FDA’s review of kratom and Florida’s kratom legislation.
- A few weeks ago, the FDA announced applications are open to support the development, implementation, and evaluation of a human abuse potential (HAP) study on kratom. This marks a significant step towards a federal understanding of the effects of kratom and how it can be best regulated.
- Also in January, Florida lawmakers unanimously approved SB 842. The bill has now been passed to the Appropriations Committee on Agriculture, Environment, and General Government for further review.
- Last summer, lawmakers and Florida’s Governor signed the Kratom Consumer Protection Act (KCPA) into law. This act bans kratom sales to those younger than 21 years old, but lacks further regulations or restrictions.
- SB 842 imposes additional, but modest, regulations on Kratom. The bill requires packages of kratom to include dosage recommendations and other labeling requirements. This bill also limits the potency of certain kratom products and prohibits selling kratom that has been mixed with harmful substances. Senator Keith Perry, sponsor of the bill, plans to widen the legislation to require all kratom products be tested by the state.
- Violators of SB 842 face a $500 fine for the first offense and a $1,000 fine for every additional offense.